$ABIO News After-hours trades still risky, a decade later

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ABIO News

After-hours trades still risky, a decade later 2:23 p.m. June 9, 2011 - Kate Gibson
Monday's biggest gaining and declining stocks 3:20 p.m. May 17, 2010 - MarketWatch
MDRNA, ARCA move on patent office updates 1:08 p.m. March 29, 2010 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 3:36 p.m. March 26, 2010 - MarketWatch
ARCA Bio surges 226% on patent 2:22 p.m. March 26, 2010 - Shawn Langlois
ARCA Biopharma shares surge 220% to $8.56 2:02 p.m. March 26, 2010 - Laura Mandaro
Monday's biggest gaining and declining stocks 3:43 p.m. June 1, 2009 - MarketWatch

Arca Biopharma: A Genetically Targeted Drug For Atrial Fibrillation In Heart Failure Patients 3:53 p.m. Jan. 10, 2014 - Seeking Alpha
FDA accepts test to be used in ARCA Biopharma trial 9:16 a.m. Jan. 8, 2014 - Seeking Alpha
Morning Market Movers 8:59 a.m. Jan. 8, 2014 - benzinga.com
ARCA Biopharma Announces FDA Acceptance of Gencaro Companion Diagnostic Test IDE 7:32 a.m. Jan. 8, 2014 - benzinga.com
FDA Clears ARCA Bio To Start Landmark Personalized Medicine Clinical Trial 10:10 a.m. Dec. 4, 2013 - Seeking Alpha
OCLS – Why Oculus Jumped Over 145% Today 8:27 a.m. Dec. 4, 2013 - InvestorPlace.com
10-Q: ARCA BIOPHARMA, INC. 4:41 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
ARCA Biopharma Announces Clinical Trial Agreement for GENETIC-AF Trial 7:35 a.m. Nov. 6, 2013 - benzinga.com
Refined And Ready To Rebound: We Like What We See At Arca Bio 8:00 a.m. Sept. 9, 2013 - Seeking Alpha
Arca Biopharma Prepares For A Second Life 4:52 p.m. Aug. 21, 2013 - Seeking Alpha
ARCA biopharma Provides Business Update 6:32 a.m. July 17, 2013 - benzinga.com
Stocks Hitting 52-Week Lows 8:23 a.m. June 13, 2013 - benzinga.com
ARCA biopharma Announces Closing of $20M Equity Offering 6:06 a.m. June 5, 2013 - benzinga.com
Afternoon Market Losers 12:31 p.m. May 30, 2013 - benzinga.com
10-Q: ARCA BIOPHARMA, INC. 4:25 p.m. May 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Market Close: Big Winners & Losers for April 23, 2013 2:51 p.m. April 23, 2013 - 247WallSt.com
Biogen Idec, Celgene And AbbVie Move To New Highs 4:24 p.m. April 22, 2013 - Investors Business Daily
Market Close: Big Winners & Losers for April 22, 2013 2:58 p.m. April 22, 2013 - 247WallSt.com
ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM 6:02 a.m. April 22, 2013 - benzinga.com
10-K: ARCA BIOPHARMA, INC. 4:23 p.m. March 21, 2013 - Edgar Online - (EDG = 10Q, 10K)


Stock Price Movements, FDA Applications, Appointments, and Clinical Study Updates - Research Report on Alere, ARCA, Achillion, Idenix Pharmaceuticals, and Receptos 8:00 a.m. Today - PR Newswire - PRF
ARCA biopharma Announces US FDA Acceptance of Gencaro Companion Diagnostic Test IDE 8:30 a.m. Jan. 8, 2014 - BusinessWire
ARCA biopharma to Present at Biotech Showcase 2014 8:30 a.m. Jan. 7, 2014 - BusinessWire
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 8:00 a.m. Dec. 9, 2013 - PR Newswire
Stocks Outperformed the Broader Markets: Facebook Inc, Twitter Inc, CF Industries Holdings, Green Mountain Coffee Roasters, Arca Biopharma 9:18 a.m. Dec. 5, 2013 - PR Newswire
ARCA biopharma Announces IDE Submission to US FDA for Gencaro Companion Diagnostic Test 8:30 a.m. Dec. 5, 2013 - BusinessWire
TrendingWallStreet.com Releases Coverage on OCLS, EXPR, ABIO, and VTMB 12:21 a.m. Dec. 5, 2013 - ACCESSWIRE
ARCA biopharma Announces US FDA Acceptance of Gencaro IND Application for the Treatment of Atrial Fibrillation 8:30 a.m. Dec. 4, 2013 - BusinessWire
ARCA biopharma Announces Resignation from Board of Directors 5:00 p.m. Nov. 21, 2013 - BusinessWire
ARCA biopharma Announces Clinical Trial Agreement for GENETIC-AF Trial 8:30 a.m. Nov. 6, 2013 - BusinessWire
VOLC, GLUU, ABIO and EROC added to NASDAQ Active Stock Watch List at EPR 9:18 a.m. Oct. 29, 2013 - ACCESSWIRE
ARCA biopharma Announces IND Submission to US FDA for Gencaro for the Treatment of Atrial Fibrillation 7:00 a.m. Oct. 29, 2013 - BusinessWire
Exclusive Video Interviews With CEOs Now on Equities.com: ABIO, INO, IVX, NETD, OPXA 7:00 a.m. Sept. 25, 2013 - GlobeNewswire
Robert E. Conway Appointed to ARCA biopharma Board of Directors 7:30 a.m. Sept. 4, 2013 - BusinessWire
ARCA biopharma to Present at the Rodman & Renshaw Annual Global Investment Conference 7:30 a.m. Aug. 21, 2013 - BusinessWire
Raymond L. Woosley, M.D., Ph.D. Appointed to ARCA biopharma Board of Directors 7:30 a.m. July 30, 2013 - BusinessWire
ARCA biopharma Announces Steering Committee for GENETIC-AF Trial 7:30 a.m. July 24, 2013 - BusinessWire
ARCA biopharma Announces Additions to GENETIC-AF Leadership Team 7:30 a.m. July 22, 2013 - BusinessWire
ARCA biopharma Provides Business Update 7:30 a.m. July 17, 2013 - BusinessWire
Gencaro(TM) Potential Efficacy in Preventing Atrial Fibrillation Paper Published in JACC: Heart Failure 7:00 a.m. June 6, 2013 - BusinessWire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EPIC Players Seeks Sponsors for 2027 Gala & Seasons

Updated Category News Views 81

Shining the Spotlight on Neurodivergent and Disabled Artists The curtains are about to rise for EPIC Players' 10th Anniversary Gala, and folks, it's more than just a party; it's a cause worth championing. Set for April 7, 2027, at New York's City Winery, this event is an invitation for brands to spotlight their support for Neurodivergent and Disabled artists. If you've...

Continue Reading
Clean Tech's Dual Role: Energy Resilience and Dependency

Updated Category News Views 102

Technology's Double-Edged Sword in Energy You ever chat with someone about moving your whole life onto solar? Seems greener and cheaper, right? But dive into the numbers, and you'll see it comes with its own set of strings attached. According to a fresh-off-the-press report from S&P Global, clean tech is both a saving grace and a looming liability economically and...

Continue Reading
FCM Travel Names New CPO to Lead AI Innovation

Updated Category News Views 36

Fresh Face at the Helm Hiring Mark McSpadden as Chief Product Officer is a move by FCM Travel that signals the company's intent to deepen its roots in tech and innovation within the corporate travel sector. There's no subtlety here—FCM's making a bold statement, and they're throwing serious weight behind their tech strategy. Don’t take this lightly; this is them...

Continue Reading
Harcum Scholarships Transform Financial Dreams to Reality

Updated Category News Views 65

The Power of Generosity in Education When you want to see hope packaged in action, look no further than Harcum College. It’s not just about tossing some dollars at a cause, it’s about igniting change. Scholarships at Harcum aren’t mere financial aids; they’re the lifelines some students desperately need. This National Scholarship Month, Harcum isn’t just patting...

Continue Reading
APhA Foundation Awards Grants for Pharmacy Innovations

Updated Category News Views 27

New Waves in Pharmacy: Grant Recipients Announced In a world where pharmacy roles are ever-expanding, the American Pharmacists Association Foundation (APhA Foundation) keeps pushing boundaries. They've just announced the lucky recipients of their 2026–2027 Incentive Grants for Practitioner Innovation in Pharmaceutical Care and Improving Immunization Implementation....

Continue Reading
Lemonade Preps for 2026 Investor Day with Webcast Plans

Updated Category News Views 35

Lemonade's Investor Day Goes Hybrid Everyone's got their eyes peeled on Lemonade's upcoming Investor Day scheduled for November 17, 2026. It's like taking a peek behind the curtain of a magician's act—will we be wowed or left scratching our heads? This year's spectacle happens in New York but gives attendees the luxury of attendance however they fancy. Lemonade's...

Continue Reading
Rival's 2026 Index Unveils Braver Challenger Routes

Updated Category News Views 51

Challenger Complacency: When Bold Isn’t Enough Anyone close to the world of aggressive marketing strategy knows that the once-innovative tactics of challenger brands are starting to blend into the wallpaper. Every player and their grandma seems to be singing from the same hymn sheet—earn attention, rub shoulders with creators, launch big splashy promos. As Rival's...

Continue Reading
Avoid Costly Checking Account Mistakes: Key Tips

Updated Category News Views 16

Oversights That Could Drain Your Wallet Let me tell you, folks skip over their checking account details like it's a doctor's recommended veggie list. Even seasoned bankers trip up on the regular. Banking Expert Trent Nelson of PriorityOne Bank spills the beans on how understanding your account could save you from costly missteps and keep unnecessary fees at bay. Turns...

Continue Reading
HNCEXPO Shenzhen 2026: A Hub for Global Health Trends

Updated Category News Views 91

Spotlight on Health and Innovation at HNCEXPO In the bustling city of Shenzhen, where skyscrapers meet the sea, HNCEXPO 2026 wrapped up a colorful spectacle, leaving a vibrant impression on the health and nutrition industry. This isn't just any trade show—it's where global innovators gather to showcase the latest in nutraceuticals, dietary supplements, and smart senior...

Continue Reading
ThirdGen Timber Expands with Major Industry Acquisitions

Updated Category News Views 37

ThirdGen Timber's Bold Play in the Market Not every day you witness a family-owned business taking substantial strides like ThirdGen Timber just did. These folks aren't merely dipping their toes; they're plunging headfirst into the timber industry waters like a pack of determined beavers. The acquisition of PrecisionCraft Log & Timber Homes, Riverbend Timber Framing,...

Continue Reading

Top 5 Most Recently Viewed Articles

Palisade Bio Faces Challenges Amid Stock Decline and Trials

Updated Category News Views 121

Palisade Bio's Stock Takes a Hit, Hitting $1.34 In the current market landscape, Palisade Bio has experienced a considerable downturn, as its shares dropped to a disappointing 52-week low of $1.34. This sharp decline signifies an 80.91% reduction over the past year, a trend that alarms investors and analysts alike. The decline in stock price not only illustrates the...

Continue Reading
Market Trends: Investors Gauge Inflation and Earnings Insights

Updated Category News Views 178

Market Updates as Investors Analyze Key Economic Indicators U.S. stock index futures experienced a noticeable uptick, buoyed by a decrease in Treasury yields. This rise comes as investors closely monitor inflation data and forthcoming corporate earnings, aiming to gauge the condition of the economy. The latest figures at 05:32 a.m. ET indicated that Dow E-minis increased...

Continue Reading
SAIHEAT Achieves Major Milestone with IAEA Approval of SMRs

Updated Category News Views 187

IAEA Endorsement: A New Era for SAIHEAT SAIHEAT Limited, known as an innovator in nuclear technology, has received significant news that the International Atomic Energy Agency (IAEA) has officially approved the company as a vendor of small modular reactors (SMRs). This approval reflects the IAEA's endorsement of SAIHEAT's conceptual designs and reactor descriptions,...

Continue Reading
Festi hf. to Release Q3 2025 Results with Investor Engagement

Updated Category News Views 174

Festi hf. Announces Q3 2025 Results Release Date Festi hf. is excited to announce that it will publish its Q3 2025 results on the last Thursday of October, marking a significant moment for both the company and its stakeholders. Investors and interested parties can expect the results to be available after the markets close, ensuring ample time for review and analysis....

Continue Reading
LivaNova Showcases Epilepsy Research at Major Conference

Updated Category News Views 134

LivaNova to Present at the American Epilepsy Society 2024 Annual Meeting LivaNova PLC (Nasdaq: LIVN), a leading medical technology firm, has announced its upcoming engagement at the American Epilepsy Society's 2024 Annual Meeting, which is set to take place from December 6 to 10. This prominent event will be an opportunity for LivaNova to highlight its innovative...

Continue Reading